-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A study led by the University of Washington School of Medicine found that if a woman contracted COVID-19 during pregnancy, even if the infection was mild, it could disrupt the placenta's immune response to further infections
The study was published in the September 17 issue of the American Journal of Obstetrics and Gynecology
Dr.
This finding is the "tip of the iceberg" of how COVID-19 might affect fetal or placental development
She noted that early in the pandemic, many people thought that COVID-19 would not seem to harm a developing fetus because very few
"But what we're seeing now is that the placenta is vulnerable to COVID-19, and infection changes the way the placenta works, which in turn could affect the development
The placenta provides nutrition, oxygen, and immune protection to the fetus until birth
"It's really challenging to study every variant in real time," Adams Waldorf said, "because they always come up so fast that we can't keep up
Whatever the variant, Adams Hordolf stressed that it is important that women do not contract COVID-19
Pregnant women should be vaccinated and fortified first, then continue to wear masks and be strictly isolated in the same vaccination and fortification population
"The disease can be mild or severe, but we can still see these abnormal effects on
In this study, a total of 164 pregnant women were studied, including 24 healthy patients who were not infected as a control group and 140 patients infected with
Placental tissue is approved by patients through the Intermountain Healthcare Research Institute Review Board in Salt Lake City, Utah or the Human Subjects Division
Brahm Coler, W.